ESSEX BIO-TECHNOLOGY
Essex Bio-Technology Limited (“EssexBio Group” and the “Company”) was incorporated in the Cayman Islands on 31st July, 2000 and has been listed on the Stock Exchange of Hong Kong since 27th June, 2001. Essex specializes in biopharmaceutical drug development based on recombinant DNA technology. It is principally engaged in the manufacture and sale of biopharmaceutical products for the treatment and healing of surface wounds and eye wounds. The Group also engaged in the research and devel... opment of bFGF products for new indications, as well as other ophthalmic pharmaceutical projects. A series of genetically engineered bio-pharmaceutical drugs have been successfully developed and three of them were classified as State-level Category I new drugs. The main brands of the Company's products are Beifuji, Beifushu and Beifuxin.
ESSEX BIO-TECHNOLOGY
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
1990-01-01
Status:
Active
Contact:
(+852) 2587 7838
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Euro Google Maps PHP Apple Mobile Web App Capable IIS Apple Mobile Web App Status Bar Style IIS 7
Similar Organizations
Pharming Group
Pharming Group is a developer and manufacturer of human therapeutic proteins.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-05-01 | X-ZELL | Essex Bio-Technology investment in Seed Round - X-ZELL | 4 M USD |
| 2018-03-16 | MeiraGTx | Essex Bio-Technology investment in Series B - MeiraGTx | 5 M USD |